Emerging Therapies for Osteoporosis
Michael R. McClung (McClung MR)
Endocrinol Metab. 2015;30(4):429-435.   Published online 2015 Dec 31     DOI: https://doi.org/10.3803/EnM.2015.30.4.429
Citations to this article as recorded by Crossref logo
The osteocyte as a signaling cell
Jesus Delgado-Calle, Teresita Bellido
Physiological Reviews.2022; 102(1): 379.     CrossRef
Effects of sclerostin antibody on bone healing
Atsushi Mihara, Kiminori Yukata, Toshihiro Seki, Ryuta Iwanaga, Norihiro Nishida, Kenzo Fujii, Yuji Nagao, Takashi Sakai
World Journal of Orthopedics.2021; 12(9): 651.     CrossRef
Potential Biomarkers to Improve the Prediction of Osteoporotic Fractures
Beom-Jun Kim, Seung Hun Lee, Jung-Min Koh
Endocrinology and Metabolism.2020; 35(1): 55.     CrossRef
Clinical Application of Teriparatide in Fracture Prevention
Yuehong Chen, Ronghan Liu, Aubryanna Hettinghouse, Shuya Wang, Gang Liu, Chuan-ju Liu
JBJS Reviews.2019; 7(1): e10.     CrossRef
The Emerging Role of Osteocytes in Cancer in Bone
Emily G Atkinson, Jesús Delgado-Calle
JBMR Plus.2019; 3(3): e10186.     CrossRef
Osteoporosis therapies might lead to intervertebral disc degeneration via affecting cartilage endplate
Zhen Sun, Zhuo-Jing Luo
Medical Hypotheses.2019; 125: 5.     CrossRef
Polymersome nanoparticles for delivery of Wnt-activating small molecules
Edoardo Scarpa, Agnieszka A Janeczek, Alethia Hailes, Maria C de Andrés, Antonio De Grazia, Richard OC Oreffo, Tracey A Newman, Nicholas D Evans
Nanomedicine: Nanotechnology, Biology and Medicine.2018; 14(4): 1267.     CrossRef
Dual roles of QOA-8a in antiosteoporosis: a combination of bone anabolic and anti-resorptive effects
Jing Wu, Qi Shen, Wei Cui, Yu Zhao, Yue Huai, Yu-chao Zhang, Bei-hua Bao, Chen-xi Liu, Qing Jiang, Jian-xin Li
Acta Pharmacologica Sinica.2018; 39(2): 230.     CrossRef
Abaloparatide: Recombinant human PTHrP (1–34) anabolic therapy for osteoporosis
Chee Kian Chew, Bart L. Clarke
Maturitas.2017; 97: 53.     CrossRef
Dried and free flowing granules of Spinacia oleracea accelerate bone regeneration and alleviate postmenopausal osteoporosis
Sulekha Adhikary, Dharmendra Choudhary, Naseer Ahmad, Sudhir Kumar, Kapil Dev, Naresh Mittapelly, Gitu Pandey, Prabhat Ranjan Mishra, Rakesh Maurya, Ritu Trivedi
Menopause.2017; 24(6): 686.     CrossRef
Romosozumab for the treatment of osteoporosis
Leonardo Bandeira, E. Michael Lewiecki, John P. Bilezikian
Expert Opinion on Biological Therapy.2017; 17(2): 255.     CrossRef
The quest for new drugs to prevent osteoporosis-related fractures
T. J. de Villiers
Climacteric.2017; 20(2): 103.     CrossRef
Role and mechanism of action of sclerostin in bone
Jesus Delgado-Calle, Amy Y. Sato, Teresita Bellido
Bone.2017; 96: 29.     CrossRef
Biochemical Testing Relevant to Bone
Chee Kian Chew, Bart L. Clarke
Endocrinology and Metabolism Clinics of North America.2017; 46(3): 649.     CrossRef
Re-Invigorating the Osteoporosis Message
Michael R. McClung
Endocrine Practice.2016; 22(9): 1130.     CrossRef
Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis
Leonardo Bandeira, E. Michael Lewiecki, John P. Bilezikian
Expert Opinion on Drug Metabolism & Toxicology.2016; 12(6): 681.     CrossRef
Osteoporosis treatment: bisphosphonates reign to continue for a few more years, at least?
Michael Pazianas, Bo Abrahamsen
Annals of the New York Academy of Sciences.2016; 1376(1): 5.     CrossRef
Anti-senescence and Anti-inflammatory Effects of the C-terminal Moiety of PTHrP Peptides in OA Osteoblasts
Julia Platas, Maria Isabel Guillén, Francisco Gomar, Miguel Angel Castejón, Pedro Esbrit, Maria José Alcaraz
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences.2016; : glw100.     CrossRef
Osteocytic signalling pathways as therapeutic targets for bone fragility
Lilian I. Plotkin, Teresita Bellido
Nature Reviews Endocrinology.2016; 12(10): 593.     CrossRef